Allen Comer, Ph.D
Senior Director of Research at Mallinckrodt Pharmaceuticals
Dr. Allen Comer is a Senior Director of Research at Mallinckrodt Pharmaceuticals. In this role, he leads the company’s research and development efforts for its pipeline products, including StrataGraft®. Dr. Comer also serves as Principal Investigator of the company’s Biomedical Advanced Research and Development Authority (BARDA) contract, which supports the late-stage development of StrataGraft.
Dr. Comer has been involved in the development of StrataGraft since 2000, holding positions of increasing responsibility in the areas of research and development, quality control, and clinical development. Prior to joining Stratatech Corporation, Dr. Comer led a series of research and development and drug discovery programs in both academia and industry.
Dr. Comer received his B.S. in Biological Sciences (Biochemistry) at North Carolina State University in Raleigh, N.C. He received his Ph.D. in Genetics at the University of North Carolina at Chapel Hill in Chapel Hill, N.C. and his fellowship in molecular genetics at the University of Wisconsin in Madison, Wis. Dr. Comer’s research has been featured in 14 publications.